EMA — authorised 27 June 2014
- Status: approved
🇪🇺 Daklinza in European Union
EMA authorised Daklinza on 27 June 2014
Marketing authorisation
Daklinza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Daklinza approved in European Union?
Yes. EMA authorised it on 27 June 2014.
Who is the marketing authorisation holder for Daklinza in European Union?
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.